Predicta Med

Predicta Med is an AI-based digital health company focused on early detection and effective treatment selection of autoimmune and immune-related diseases.

Health Tech & Life Sciences
Active
Seed Ramat Gan, Israel Founded 2020
Last updated 2026-07-26
Total raised
$1.0M
Last: Grant 2024-01
Stage
Seed
Founded
2020
Headcount
21
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

Predicta Med is an Israeli digital health startup that has developed an AI-driven platform for the early detection and intervention of autoimmune diseases. The company's PredictAI™ platform aggregates and analyzes electronic medical records (EMR) and claims data using advanced machine learning techniques to identify patients at risk of immune-related conditions. The platform aims to shorten the diagnostic journey for autoimmune diseases, which can currently take years, and empower primary care physicians with actionable insights for optimal intervention and personalized care. Predicta Med's technology focuses on seven autoimmune diseases: multiple sclerosis, celiac disease, Crohn's disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis. The company collaborates with leading healthcare providers and medical advisors from institutions like Stanford Medicine, Mayo Clinic, Columbia University, and Sheba Hospital.

Funding history · 1 round · $1.0M total

2023-12
Grant $1.0M

Headcount over time

From 1 (2019-10) to 21 (2026-03) · +20 (+2000%) · 25 points · source: Finder history + radar grounding
220 2019-10 2026-03

Q&A

What is Predicta Med's primary focus?
Predicta Med is an AI-based digital health company specializing in the early detection and effective treatment selection for autoimmune and immune-related diseases.
When was Predicta Med founded?
Predicta Med was founded in 2020.
How many employees does Predicta Med currently have?
Predicta Med has 21 employees, falling within the 11-50 employee bucket.
What is the total amount of funding Predicta Med has raised to date?
Predicta Med has raised a total of $5,500,000 USD.
When did Predicta Med receive its most recent funding?
Predicta Med received a Grant of $1,000,000 in January 2024.
What is the name of Predicta Med's AI platform?
Predicta Med's AI-driven platform is called PredictAI™.
Which autoimmune diseases does Predicta Med's technology focus on?
Predicta Med's technology focuses on seven autoimmune diseases: multiple sclerosis, celiac disease, Crohn's disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis.

Team · 2

Shlomit Steinberg-Koch
Founder · CEO
Benny Getz
Founder · CTO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceDeep LearningNatural Language Processing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

osteoarthritismultiple-sclerosisrecommendationsdiagnosticsceliac-diseaseemralgorithmsautoimmune-diseasesdecision-supportdigital-healthcaremedical-dataartificial-intelligenceearly-detection
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepredicta-med.com/
LinkedInlinkedin.com/company/26208861

Identifiers & details

Legal namePredicta Med Analytics LTD
Founded2020
Employees (exact)21

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainpredicta-med.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516150240
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2020-01-29
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressתובל 40 רמת גן